Clinical Trial Update: Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1 [Phase 3]

View source ↗

Summary

This clinical trial update reports the start of Phase 3 evaluation for a treatment targeting Immunoglobulin A nephropathy (IgA nephropathy) to assess effectiven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunoglobulin Nephropathy

Snippet

Sponsor: Ewha Womans University | Conditions: Glomerulonephritis, Immunoglobulin A (IgA) | Phase 3 | Status: UNKNOWN